Savant Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Buy |
17,076
+4,514
| +36% | +$546K | 0.01% | 556 |
|
|
2025
Q1 | $1.4M | Buy |
12,562
+1,180
| +10% | +$132K | 0.01% | 636 |
|
|
2024
Q4 | $1.11M | Buy |
11,382
+11
| +0.1% | +$1.07K | 0.01% | 610 |
|
|
2024
Q3 | $1.31M | Buy |
11,371
+5,908
| +108% | +$680K | 0.01% | 556 |
|
|
2024
Q2 | $582K | Buy |
5,463
+56
| +1% | +$5.96K | 0.01% | 740 |
|
|
2024
Q1 | $523K | Sell |
5,407
-2,096
| -28% | -$203K | 0.01% | 716 |
|
|
2023
Q4 | $758K | Buy |
7,503
+3,738
| +99% | +$377K | 0.01% | 470 |
|
|
2023
Q3 | $384K | Sell |
3,765
-332
| -8% | -$33.8K | 0.01% | 591 |
|
|
2023
Q2 | $413K | Buy |
4,097
+559
| +16% | +$56.4K | 0.01% | 554 |
|
|
2023
Q1 | $326K | Sell |
3,538
-21
| -0.6% | -$1.93K | 0.01% | 577 |
|
|
2022
Q4 | $276K | Buy |
+3,559
| New | +$276K | 0.01% | 482 |
|
|
2022
Q3 | – | Sell |
-3,034
| Closed | -$256K | – | 560 |
|
|
2022
Q2 | $256K | Buy |
3,034
+196
| +7% | +$16.5K | 0.01% | 465 |
|
|
2022
Q1 | $249K | Sell |
2,838
-24
| -0.8% | -$2.11K | 0.01% | 494 |
|
|
2021
Q4 | $250K | Buy |
2,862
+326
| +13% | +$28.5K | 0.01% | 484 |
|
|
2021
Q3 | $207K | Sell |
2,536
-217
| -8% | -$17.7K | 0.01% | 497 |
|
|
2021
Q2 | $251K | Sell |
2,753
-217
| -7% | -$19.8K | 0.01% | 432 |
|
|
2021
Q1 | $254K | Sell |
2,970
-30
| -1% | -$2.57K | 0.01% | 398 |
|
|
2020
Q4 | $283K | Buy |
3,000
+7
| +0.2% | +$660 | 0.02% | 361 |
|
|
2020
Q3 | $260K | Sell |
2,993
-179
| -6% | -$15.6K | 0.02% | 346 |
|
|
2020
Q2 | $277K | Buy |
3,172
+404
| +15% | +$35.3K | 0.02% | 336 |
|
|
2020
Q1 | $228K | Buy |
+2,768
| New | +$228K | 0.02% | 339 |
|